Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Early bits of in vivo CAR-T human data emerge from biotech trials in China
6 days ago
R&D
Cell/Gene Tx
Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies
Last week
Pharma
AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs near
Last week
Pharma
Manufacturing
AstraZeneca posts another Truqap study fail, says China import tax could triple
Last week
Pharma
Law
WuXi AppTec sees growth after 2024 dip, plans ‘lean’ operations to temper ‘external opportunities’
Last week
Pharma
Manufacturing
Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval
3 weeks ago
R&D
Drugmakers see a substantial, but manageable, hit to business from tariffs. But the worst may lie ahead
3 weeks ago
Pharma
Thermo Fisher buckles up for US-China trade war, budgets $2B to ease impact
3 weeks ago
Pharma
Manufacturing
Merck’s Gardasil sales sink further amid China market pressure
3 weeks ago
Pharma
China’s biotech market is staging a comeback that US biotech can only wish for
3 weeks ago
Deals
Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs
3 weeks ago
Pharma
Manufacturing
China startup injects CRISPR therapy into the brain for the first time
3 weeks ago
Startups
R&D
Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms
4 weeks ago
Startups
Deals
BioNTech-backed ADC maker DualityBio plans IPO on Hong Kong exchange
4 weeks ago
Financing
Startups
Amid Trump’s research cuts, commission says US risks losing biotech race without $15B investment
Last month
Pharma
ADC startup DualityBio seeks Hong Kong IPO amid precarious market
Last month
Financing
Startups
China's retaliatory tariffs on US could mean more headwinds for drugmakers
Last month
Pharma
Manufacturing
F-star management takes company private, two years after $161M cash exit to Sino's invoX
Last month
Deals
WuXi Biologics’ licensing deals help offset Biosecure threat in the US
Last month
Deals
Manufacturing
Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui
Last month
Deals
Pharma
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China
Last month
R&D
Manufacturing
AstraZeneca broadens presence in China, promising $8B+ to Harbour and Syneron
Last month
Deals
Pharma
Ascendis’ China joint venture, Visen Pharmaceuticals, prices $86M Hong Kong IPO
Last month
Financing
Startups
WuXi AppTec's US revenue growth continues to dip in post-Biosecure environment
Last month
Pharma
Manufacturing
1
2
3
4
Next page
Last page
